Clinical Trials Browser

Phase 4 × Non-alcoholic Fatty Liver Disease × Clear all

NCT02500147 2025-07-02

Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)

Phase 4 Terminated

3 enrolled 5 charts

Acne Vulgaris, Amenorrhea, Hirsutism, Polycystic Ovary Syndrome, Metabolic Syndrome, Dyslipidemias, Non-alcoholic Fatty Liver Disease

NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Phase 4 Active not recruiting

LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

NCT06256289 2024-02-13

Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome

Phase 4 Unknown

Polycystic Ovary Syndrome, Non-alcoholic Fatty Liver Disease